The non-Hodgkin's lymphoma subtypes distribution and survival in Czech Republic;Distribuce podtypů non-Hodgkinského lymfomu v České Republice a jejich přežití

Klinicka Onkologie

Volumn 20, Issue 5, 2007, Pages 340-348

  Trneny M ^a   Vasova I ^b   Pytlik R ^a   Belada, C D ^j   Jankovska M ^d   Kubackova E K ^j   Salkova J ^a   Koleskova E ^a   Hofmanova Z ^b   Hrabetova S ^d   Kajaba, V ^e   Sykorova A ^c   Pirnos, J ^f   Pribylova J ^g   Svecova J ^h   Ciberova J ⁱ   Bolomska I ^j   Skacelikova E ^j   Brejcha, M ^k   Adamova D ^l   Frankova H ^m   Barsova L ⁿ   Benesova K ^j   Senigl V ^o   Campr, V ^a   Boudova L ^p   Stritesky J ^a   Petrova M ^q   Krejcova H ^q   Prochazka B ^r   Klener, P ^a   more..

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^f Kardiochirurgické odd lení Kardiocentrum Nemocnice eské Bud jovice   (Czech Republic)

^g Nemocnice Chomutov oz   (Czech Republic)

^h Nemocnice Tabor   (Czech Republic)

ⁱ Orko   (Czech Republic)

^j FNSP Ostrava Poruba ^*

^k Onkologické Centrum J G Mendela

^l HTO   (Czech Republic)

^m Gynekologicko porodnické oddelení Nemocnice Trebíc   (Czech Republic)

ⁿ Nemocnice Liberec   (Czech Republic)

^o O ní odd lení Nemocnice Kolín   (Czech Republic)

^p CHARLES UNIVERSITY   (Czech Republic)

^q CHARLES UNIVERSITY   (Czech Republic)

^r NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

more..

Author keywords

Distribution; Incidence; Non Hodgkin's lymphoma; Registries; Survival

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ANAPLASTIC CARCINOMA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CZECH REPUBLIC; DISEASE FREE SURVIVAL; FOLLICULAR LYMPHOMA; GEOGRAPHIC DISTRIBUTION; HUMAN; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MEDICAL LITERATURE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PROBABILITY; PUBLICATION; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

EID: 35348960965     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bray I, Brennan P, Boffetta P. Recent trends and future projections of lymphoid neoplasms - a Bayesian age-period-cohort analysis. Cancer Causes Control. 2001;12:813-820.
2. Olsen JH. Epidemiology. In: Degos L, Linch D, Lowenberg B, eds. Malignant Hematology. London: Mark Dunitz; 1999:1-22.
3. UK Non-Hodgkin lymphoma incidence statistics. http://infocancer- researchukorg/cancerstats/types/nhl/incidence/. 2007.
4. Edwards BK, Howe HL, Ries LA et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766-2792.
5. Cancer Incidence 1999 in Czech Republic. UZIS CR, NOR CR; 2001.
6. Cancer Incidence 2003 in the Czech Republic. Praha: UZIS, NOR CR; 2006.
7. Geryk E, Kolcova V, Zacek V. Trendy poctu onkologicky nemocnych v Ceske republice. Brno: NOR,MOU; 2000.
8. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]. Blood. 1994;84:1361-1392.
9. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. Lyon: IARC Press; 2001.
10. Shipp MA, Harrington DP, Anderson JR et al. A Predictive Model for Aggressive Non-Hodgkins Lymphoma. N Engl J Med. 1993;329:987-994.
11. Solal-Celigny P, Roy P, Colombat P et al. Follicular Lymphoma International Prognostic Index. Blood. 2004;104:1258-1265.
12. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244.
13. Cheson BD, Pfistner B, Juweid ME et al. Revised Response Criteria for Malignant Lymphoma. J Clin Oncol. 2007.
14. Chan WC, Armitage JO, Gascoyne R et al. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
15. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-2795.
16. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non- Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998;9:717-720.
17. Gascoyne RD, Aoun P, Wu D et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93:3913-3921.
18. Savage KJ, Al Rajhi N, Voss N et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol. 2006;17:123-130.
19. Hermans J, Krol AD, van Groningen K et al. International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood. 1995;86:1460-1463.
20. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235-242.
21. Pfreundschuh M, Trumper L, Osterborg A et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7:379-391.
22. Sehn LH, Donaldson J, Chhanabhai M et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol. 2005;23:5027-5033.